Bob Marley Estate Sues Over $11.3M Cannabis Royalties

Even decades after his passing, Bob Marley’s legacy continues to generate significant income, but now his estate is embroiled in a legal battle over millions in unpaid royalties. The iconic reggae artist, who died in 1981, was posthumously recognized as one of the highest-earning deceased celebrities in 2025, raking in $13 million through various licensed products.

The Genesis of Marley Natural

Back in 2014, Bob Marley’s family, managing his estate, partnered with Privateer Holdings to launch Marley Natural. This venture was billed as the world’s first global cannabis brand, offering a range of products from cannabis-infused lotions to accessories. Cedella Marley, Bob’s daughter, expressed at the time how proud her father would have been to see the healing potential of cannabis recognized.

Brendan Kennedy, the CEO of Privateer Holdings, echoed this sentiment, calling the partnership a “natural fit” given Bob Marley’s strong association with cannabis. The brand aimed to connect Marley’s spirit with the burgeoning cannabis market.

Legal Battles Emerge

Fast forward to 2026, and the situation has taken a legal turn. The Bob Marley estate has filed a lawsuit against Tilray, a company that merged with Privateer Holdings in 2019. This legal action stems from alleged inconsistencies in royalty payments that began after Tilray and Aphria joined forces in 2021, creating a major player in the global cannabis industry.

The estate claims that by 2023, the unpaid royalties had accumulated to an estimated $13 million. This led the Marley family to terminate their licensing agreement, accusing Tilray of engaging in an “elaborate scheme to defraud” them. Despite the legal dispute, Marley Natural products continue to be sold across the U.S. and Canada.

Seeking Significant Damages

The lawsuit, filed in Delaware Court of Chancery, is seeking approximately $11.3 million in damages. This figure represents the outstanding amount after a $1.7 million settlement was reached with an associated entity. The case highlights the complexities and potential pitfalls in managing celebrity estates and brand licensing in rapidly evolving industries like cannabis.